Exousia Bio, Inc. (LMMY) Net margin 2024–2025
Exousia Bio, Inc. (LMMY) net profit margin by fiscal year — reported net income divided by reported revenue.
1370.5%FY2025 · since FY2024: -224.4% → 1370.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 1370.5% | +1594.9 pp |
| FY2024 | -224.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LMMY financial trends
LMMY RevenueLMMY Net incomeLMMY Gross profitLMMY Gross marginLMMY Operating incomeLMMY Operating marginLMMY Operating cash flowLMMY Free cash flowLMMY Capital expendituresLMMY Return on equityLMMY Stock buybacksLMMY Dividends paidLMMY Total assetsLMMY Total liabilitiesLMMY Shareholders’ equityLMMY overview →